Delivery Order SPE2DB24D1201-SPE2DB25FJEDK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) valued at $10,076.28. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $34,374.97 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count units) on August 5, 2025, with completion targeted for August 6, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical procurement executed under competitive procedures. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) valued at $4,037.23. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $5,755.12. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $25,697.77 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,821.01 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count packages). This competitively awarded, firm fixed-price delivery order was executed on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $29,045.67 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a primary...
- The Defense Logistics Agency awarded a $25,044.82 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Myrbetriq ER 50 mg tablets in a 90-count configuration, with a ceiling value of $6,187.69. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,923.12 to AmerisourceBergen Drug Corp for Myrbetriq ER 25 mg tablets (90-count supply) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEDKDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $28,074.21 on September 10, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count supply). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its broader federal contract portfolio supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract serves as a global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's competitively awarded federal contracts demonstrate its capability to fulfill diverse medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.1k | 9/10/25 |